Fig. 5From: Migraine induction with calcitonin gene-related peptide in patients from erenumab trialsHeadache intensity after CGRP and placebo. Individual headache intensity scores on the CGRP day (a) and placebo day (b). Black lines: Median intensity at each time point. The median headache intensity was 0 for all time points after placebo. The median time (range) to onset of migraine was 50 min (20–152.5) after CGRPBack to article page